U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 020702

Expand all

LIPITOR (ATORVASTATIN CALCIUM)
EQ 10MG BASE
Marketing Status: Prescription
Active Ingredient: ATORVASTATIN CALCIUM
Proprietary Name: LIPITOR
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 10MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N020702
Product Number: 001
Approval Date: Dec 17, 1996
Applicant Holder Full Name: UPJOHN MANUFACTURING IRELAND UNLTD
Marketing Status:  Prescription
Patent and Exclusivity Information
LIPITOR (ATORVASTATIN CALCIUM)
EQ 20MG BASE
Marketing Status: Prescription
Active Ingredient: ATORVASTATIN CALCIUM
Proprietary Name: LIPITOR
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 20MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N020702
Product Number: 002
Approval Date: Dec 17, 1996
Applicant Holder Full Name: UPJOHN MANUFACTURING IRELAND UNLTD
Marketing Status:  Prescription
Patent and Exclusivity Information
LIPITOR (ATORVASTATIN CALCIUM)
EQ 40MG BASE
Marketing Status: Prescription
Active Ingredient: ATORVASTATIN CALCIUM
Proprietary Name: LIPITOR
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 40MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N020702
Product Number: 003
Approval Date: Dec 17, 1996
Applicant Holder Full Name: UPJOHN MANUFACTURING IRELAND UNLTD
Marketing Status:  Prescription
Patent and Exclusivity Information
LIPITOR (ATORVASTATIN CALCIUM)
EQ 80MG BASE
Marketing Status: Prescription
Active Ingredient: ATORVASTATIN CALCIUM
Proprietary Name: LIPITOR
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 80MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N020702
Product Number: 004
Approval Date: Apr 7, 2000
Applicant Holder Full Name: UPJOHN MANUFACTURING IRELAND UNLTD
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top